See the DrugPatentWatch profile for yervoy

The mortality rate associated with Yervoy's side effects is not explicitly stated in the available information. Yervoy, also known as ipilimumab, is an immunotherapy drug used to treat certain types of cancer, including melanoma and colorectal cancer. Like many medications, Yervoy can cause side effects, some of which can be severe or life-threatening [1].

The most common side effects of Yervoy include fatigue, diarrhea, skin rash, and itching. More severe side effects can affect various body systems, such as the gastrointestinal, hepatic, dermatologic, endocrine, and nervous systems [1]. Severe side effects may lead to complications and, in rare cases, death. However, the sources do not provide specific data on the number of fatalities directly attributable to Yervoy's side effects.

It is essential to consult healthcare professionals for personalized information about the risks and benefits of Yervoy and other medications. Healthcare providers can help patients understand the potential side effects and closely monitor them during treatment [1].

Sources:

1. [Yervoy (ipilimumab) prescribing information](https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125287s025s026lbl.pdf)